We are live on ! Find out more
OA

Operose Advisors Portfolio holdings

AUM $517M
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.18%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
10 Year Est. Return
AUM
$517M
AUM Growth
+$86.2M
Cap. Flow
+$30.7M
Cap. Flow %
5.93%
Top 10 Hldgs %
61.78%
Holding
698
New
105
Increased
78
Reduced
169
Closed
176

Sector Composition

Rank Sector Weight
1 Miscellaneous 81.84%
2 Technology 6.54%
3 Financials 3.42%
4 Communication Services 2.47%
5 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEG icon
201
Constellation Energy
CEG
$98.1B
$136K 0.03%
548
+371
+210% +$104K
DFSV
202
Dimensional US Small Cap Value ETF
DFSV
$8.34B
$133K 0.03%
3,428
-539
-14% -$20.1K
COF icon
203
Capital One
COF
$132B
$131K 0.03%
653
-5
-0.8% -$956
IWL icon
204
iShares Russell Top 200 ETF
IWL
$2.26B
$129K 0.03%
+700
New +$126K
PRE icon
205
Prenetics Global
PRE
$432M
$129K 0.02%
+6,750
New +$125K
HON icon
206
Honeywell
HON
$68.9B
$129K 0.02%
576
-698
-55% -$156K
VGT icon
207
Vanguard Information Technology ETF
VGT
$147B
$128K 0.02%
1,073
+41
+4% +$4.49K
SPDW icon
208
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
$128K 0.02%
2,531
-288
-10% -$14.3K
CHWY icon
209
Chewy
CHWY
$9.52B
$127K 0.02%
6,487
-140
-2% -$3.18K
HONA
210
Honeywell Aerospace
HONA
$51.5B
$127K 0.02%
+576
New +$127K
KO icon
211
Coca-Cola
KO
$386B
$126K 0.02%
1,555
-428
-22% -$33.8K
DIVO icon
212
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.9B
$126K 0.02%
+2,750
New +$126K
CGDV icon
213
Capital Group Dividend Value ETF
CGDV
$38.8B
$126K 0.02%
2,550
-233
-8% -$11K
XLU icon
214
State Street Utilities Select Sector SPDR ETF
XLU
$21.9B
$126K 0.02%
2,771
-2,229
-45% -$101K
EMB icon
215
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$125K 0.02%
1,300
-14
-1% -$1.34K
PG icon
216
Procter & Gamble
PG
$334B
$124K 0.02%
+846
New +$123K
SCHM icon
217
Schwab US Mid-Cap ETF
SCHM
$14.9B
$123K 0.02%
3,326
+10
+0.3% +$344
EPD icon
218
Enterprise Products Partners
EPD
$84.3B
$121K 0.02%
3,300
BBC icon
219
Virtus Biotech Clinical Trials ETF
BBC
$50.6M
$120K 0.02%
+2,274
New +$101K
OKLO
220
Oklo
OKLO
$7.47B
$119K 0.02%
2,270
-930
-29% -$58K
ORCL icon
221
Oracle
ORCL
$435B
$117K 0.02%
801
+223
+39% +$40.4K
GRID
222
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$11.7B
$117K 0.02%
612
+2
+0.3% +$376
IWP icon
223
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$117K 0.02%
800
+304
+61% +$41.9K
CRWV
224
CoreWeave
CRWV
$46.5B
$116K 0.02%
+1,169
New +$126K
QUAL icon
225
iShares MSCI USA Quality Factor ETF
QUAL
$47.8B
$115K 0.02%
524
-227
-30% -$47.6K

Similar funds

Operose Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Operose Advisors held 698 positions worth $517M, up 20% from $431M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Operose Advisors deployed $30.7M of net new capital in Q2 2026, opening 105 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 15,759 shares worth $11.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, up from 81% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Growth ETF, an estimated $1.34M trimmed.

  • Operose Advisors's largest Q2 2026 buy was State Street SPDR S&P 500 ETF Trust: 15,759 shares worth $11.8M.
  • Operose Advisors added most to Vanguard FTSE Developed Markets ETF in Q2 2026, an estimated $5.16M increase.
  • Operose Advisors's biggest Q2 2026 reduction was Vanguard Morningstar Mid-Cap Growth ETF, cutting an estimated $1.34M.
  • Operose Advisors fully exited ExxonMobil in Q2 2026, selling an estimated $1.38M.
  • Operose Advisors's ten largest holdings make up 62% of its $517M portfolio in Q2 2026.
  • Operose Advisors opened 105 new positions and closed 176 in Q2 2026.
  • Operose Advisors's portfolio value rose 20% quarter-over-quarter to $517M.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.